AL-8810: A novel prostaglandin F(2α) analog with selective antagonist effects at the prostaglandin F(2α) (FP) receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1278-1284

  Griffin, Brenda W ^a   Klimko, Peter ^a   Crider, Julie Y ^a   Sharif, Najam A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; 9,15 DIHYDROXY 11 FLUORO 15 (2 INDANYL) 16,17,18,19,20 PENTANOR 5,13 PROSTADIENOIC ACID; 9BETA CHLORO 15 CYCLOHEXYL 9 DEOXY 16,17,18,19,20 PENTANOR 3 OXAPROSTAGLANDIN F2 ALPHA; CLOPROSTENOL; FLUPROSTENOL; PHOSPHOLIPASE C; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RS 93520; SC 51089; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG COMPETITION; DRUG SELECTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; THORACIC AORTA;

3T3 CELLS; ANIMALS; AORTA, THORACIC; CATTLE; CELLS, CULTURED; CHO CELLS; CRICETINAE; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MICE; MUSCLE, SMOOTH, VASCULAR; RATS; RECEPTORS, PROSTAGLANDIN;

EID: 0032774749     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Abramovitz M, Adam M, Boie Y, Grygorczyk R, Rushmore TH, Nguyen T, Funk CD, Bastien I, Sawyer N, Rochette C, Slipetz DM and Metters KM (1995) Human prostanoid receptors: Cloning and characterization. Adv Prostaglandins Thromboxane Leukotriene Res 23:499-504.
2. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM and Grygorczyk T (1994) Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269:2632-2636.
3. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
4. Bhattacherjee P and Paterson CA (1994) Studies on prostanoid receptors in ocular tissues. J Ocular Pharmacol Ther 10:167-175.
5. Bito LZ (1997) Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect. Surv Ophthalmol 41 (Suppl 22):S1-S14.
6. Blair IA, Hensby CN and McDermot J (1980) Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic hybrid: Prostanoid structure-activity relationships. Br J Pharmacol 68:519-525.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Coleman RA, Kennedy I, Humphrey PPA, Bunce K and Lumley P (1990) Prostanoids and their receptors, in Comprehensive Medicinal Chemistry: Membranes and Receptors (Emmett JC ed) vol 3, pp 643-714, Pergamon Press, Oxford, UK.
9. Coleman RA, Smith WL and Narumiya S (1994) International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 48:205-229.
10. 2 receptor in human nonpigmented ciliary epithelial cells. J Ocular Pharmacol Ther 14:293-304.
11. 2-, and IP-prostaglandin receptors in ocular and other cell types. Prostaglandins Leukot Essent Fatty Acids 59:77-82.
12. Crider JY, Griffin BW and Sharif NA (1999) Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: Pharmacological characterization using agonists and antagonists. Br J Pharmacol 127:204-210.
13. 2+ in bovine luteal cells. Proc Natl Acad Sci USA 84:3728-3732.
14. Davis TL and Sharif NA (1999) Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J Ocular Pharmacol Ther, 15:323-336.
15. Delaey C and Van de Voorde J (1995) Prostanoid-induced contractions are blocked by sulfonylureas. Eur J Pharmacol 280:179-184.
16. Furchgott RF (1972) The classification of adrenoreceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory, in Handbook of Experimental Pharmacology, Catecholamines (Blaschko H and Muscholl E eds) vol 33, pp 283-335, Springer-Verlag, Berlin.
17. Giles H, Leff P, Bolofo ML, Kelly MG and Robertson AD (1989) The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective, and potent competitive antagonist. Br J Pharmacol 96:291-300.
18. Griffin BW, Magnino PE, Pang I-H and Sharif NA (1998) Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther 288:411-418.
19. Griffin BW, Williams GW, Crider JY and Sharif NA (1997) FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study. J Pharmacol Exp Ther 281:845-854.
20. 2-responsive cell line from bovine embryonic trachia. Br J Pharmacol 99:13-14.
21. 2-receptor stimulated cyclic AMP synthesis in cultured human non-pigmented ciliary epithelium. Exp Eye Res 58:563-566.
22. 2α receptor in cultured rat astrocytes. J Neurochem 60:704-708.
23. 2α receptor. FEBS Lett 355:317-325.
24. 4 receptors positively coupled to adenylate cyclase. Br J Pharmacol 113 (Suppl):8P.
25. 4 and FP in human lens epithelial cells. Invest Ophthalmol Vis Sci 40:105-112.
26. Narumiya S (1994) Prostanoid receptors: Structure, function, and distribution, in Cellular Generation, Transport, and Effects of Eicosanoids: Biological Roles and Pharmacological Intervention (Goetzl EJ, Lewis RA and Rola-Pleszczynski M eds) pp 126-138, The New York Academy of Sciences, New York.
27. 2 alpha receptor in rat tissues. Prostaglandins Leukot Essent Fatty Acids 57:527-532.
28. Ogletree ML, Harris DN, Greenberg R, Haslanger MF and Nakane M (1985) Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234:435-441.
29. Pierce KL, Bailey TJ, Hoyer PB, Gil DW, Woodward DF and Regan JW (1997) Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J Biol Chem 272:883-887.
30. 2α receptor. J Biol Chem 269:3881-3886.
31. 3H] 9β-(+)-fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor. J Pharm Pharmacol 51:686-694.
32. 3, and FP prostaglandin receptor binding sites in bovine corpus luteum: Characterization and correlation with functional data. J Pharmacol Exp Ther 288:1094-1102.
33. 1-selective antagonist for ocular use. Receptor binding and second messenger studies. J Ocular Pharmacol 10:653-664,
34. 2 alpha. J Pharmacol Exp Ther 220:521-525.
35. Sugimoto Y, Hasumoto K-Y, Namba T, Irie A, Katsuyama M, Negishi M, Kakizuka A, Narumiya S and Ichikawa A (1994) Cloning and expression of a cDNA for mouse proataglandin F receptor. J Biol Chem 269:1356-1360.
36. 1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129: 2845-2856.
37. 2, and their esters in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 31:2466-2470.
38. 2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response. Adv Prostaglandin Thromboxane Leukot Res 21: 367-370.